Bioton S.a.
BIO.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 248 | PLN 310 | PLN 289 | PLN 359 |
| - Cash | PLN 7 | PLN 4 | PLN 9 | PLN 9 |
| + Debt | PLN 57 | PLN 69 | PLN 76 | PLN 110 |
| Enterprise Value | PLN 298 | PLN 375 | PLN 356 | PLN 461 |
| Revenue | PLN 208 | PLN 182 | PLN 233 | PLN 163 |
| % Growth | 14.4% | -22.1% | 43% | – |
| Gross Profit | PLN 65 | PLN 73 | PLN 96 | PLN 76 |
| % Margin | 31.2% | 40.1% | 41.1% | 46.8% |
| EBITDA | PLN 33 | PLN 31 | PLN 59 | PLN 45 |
| % Margin | 15.7% | 17.2% | 25.1% | 27.7% |
| Net Income | -PLN 16 | PLN 2 | PLN 1 | PLN 3 |
| % Margin | -7.5% | 1.3% | 0.6% | 1.8% |
| EPS Diluted | -0.18 | 0.027 | 0.017 | 0.034 |
| % Growth | -779.2% | 60.6% | -50.9% | – |
| Operating Cash Flow | PLN 36 | PLN 40 | PLN 56 | PLN 6 |
| Capital Expenditures | -PLN 12 | -PLN 44 | -PLN 30 | -PLN 13 |
| Free Cash Flow | PLN 25 | -PLN 5 | PLN 27 | -PLN 7 |